XML 30 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Restatement of Previously Issued Financial Statements (Tables)
 12 Months Ended
Dec. 31, 2022
Restatement of Previously Issued Financial Statements [Abstract]  
Restatement of Previously Issued Financial Statements
The impact of the restatement on the statements of operations, statements of changes in shareholders’ deficit and statements of cash flows for the Affected Period is presented below. The restatement had no impact on net cash flows from operating, investing or financing activities.

Statements of Operations:


 
  
For the Three Months Ended September 30, 2022 (unaudited)
  
 
  
As Previously Reported
    
Restatement Adjustment
    
As Restated
  
 
                  
Loss from operations
   $
(180,405
)
   $
-
     $
(180,405
)
Gain from settlement of deferred underwriting commissions
    
2,616,250
      
(2,616,250
)
    
-
  
Unrealized gain on investments held in Trust Account
    
745,227
      
-
      
745,227
  
Net income
  
$
3,181,072
    
$
(2,616,250
)
  
$
564,822
  
 
                        
Basic and diluted weighted average shares outstanding of Class A ordinary shares
    
15,449,000
       -
      
15,449,000
  
Basic and diluted net income per share, Class A ordinary share
  
$
0.17
    
$
(0.14
)
  
$
0.03
  
Basic and diluted weighted average shares outstanding of Class B ordinary shares
    
3,737,500
       -      
3,737,500
  
Basic and diluted net income per share, Class B ordinary share
  
$
0.17
    
$
(0.14
)
  
$
0.03
  
 
                        


 
  
For the Nine Months Ended September 30, 2022 (unaudited)
  
 
  
As Previously Reported
    
Restatement Adjustment
    
As Restated
  
 
                  
Loss from operations
   $
(737,938
)
   $
-
     $
(737,938
)
Gain from settlement of deferred underwriting commissions
    
2,616,250
      
(2,616,250
)
    
-
  
Unrealized gain on investments held in Trust Account
    
895,570
      
-
      
895,570
  
Net income
  
$
2,773,882
    
$
(2,616,250
)
  
$
157,632
  
 
                        
Basic and diluted weighted average shares outstanding of Class A ordinary shares
    
15,449,000
       -      
15,449,000
  
Basic and diluted net income per share, Class A ordinary share
  
$
0.14
    
$
(0.13
)
  
$
0.01
  
Basic and diluted weighted average shares outstanding of Class B ordinary shares
    
3,737,500
       -      
3,737,500
  
Basic and diluted net income per share, Class B ordinary share
  
$
0.14
    
$
(0.13
)
  
$
0.01
  


Statements of Changes in Shareholders’ Deficit

For the three months ended September 30, 2022
  
 
                                                      
 
  
Ordinary Shares
    
Additional Paid-in Capital
    
Accumulated Deficit
    
Total Shareholder's Deficit
  
 
  
Class A
    
Class B
    
As Previously Reported
    
Restatement Adjustment
    
As Restated
  
 
  
Shares
    
Amount
    
Shares
    
Amount
  
Balance - June 30, 2022 (unaudited)
    
499,000
     $
50
      
3,737,500
     $
374
     $
-
     $
(10,805,600
)
   $
-
     $
(10,805,600
)
   $
(10,805,176
)
Adjustment of accretion of Class A ordinary shares subject to possible redemption
    
-
      
-
      
-
      
-
      
-
      
(745,227
)
    
2,616,250
      
1,871,023
      
1,871,023
  
Net income
    
-
      
-
      
-
      
-
      
-
      
3,181,072
      
(2,616,250
)
    
564,822
      
564,822
  
Balance - September 30, 2022 (unaudited)
    
499,000
    
$
50
      
3,737,500
    
$
374
    
$
-
    
$
(8,369,755
)
  
$
-
    
$
(8,369,755
)
  
$
(8,369,331
)

For the nine months ended September 30, 2022
  
 
                                                      
 
  
Ordinary Shares
    
Additional Paid-in Capital
    
Accumulated Deficit
    
Total Shareholder's Deficit
  
 
  
Class A
    
Class B
    
As Previously Reported
    
Restatement Adjustment
    
As Restated
  
 
  
Shares
    
Amount
    
Shares
    
Amount
  
Balance - December 31, 2021
    
499,000
     $
50
      
3,737,500
     $
374
     $
-
     $
(10,295,731
)
   $
-
     $
(10,295,731
)
   $
(10,295,307
)
Adjustment of accretion of Class A ordinary shares subject to possible redemption
    
-
      
-
      
-
      
-
      
-
      
(847,906
)
    
2,616,250
      
1,768,344
      
1,768,344
  
Net income
    
-
      
-
      
-
      
-
      
-
      
2,773,882
      
(2,616,250
)
    
157,632
      
157,632
  
Balance - September 30, 2022 (unaudited)
    
499,000
    
$
50
      
3,737,500
    
$
374
    
$
-
    
$
(8,369,755
)
  
$
-
    
$
(8,369,755
)
  
$
(8,369,331
)


Statements of Cash Flow

 
 
  
For the Nine Months Ended September 30, 2022 (unaudited)
  
 
  
As Previously Reported
    
Restatement Adjustment
    
As Restated
  
Cash Flows from Operating Activities:
                  
Net income
  
$
2,773,882
    
$
(2,616,250
)
  
$
157,632
  
Adjustments to reconcile net income to net cash used in operating activities:
                        
Gain from settlement of deferred underwriting commissions
    
(2,616,250
)
    
2,616,250
      
-
  
Unrealized gain on investments held in Trust Account
    
(895,570
)
    
-
      
(895,570
)
Changes in operating assets and liabilities
     304,828       -      
304,828
  
Net cash used in operating activities
    
(433,110
)
    
-
      
(433,110
)
 
                        
Net cash used in financing activities
    
(45,000
)
    
-
      
(45,000
)
 
                        
Net change in cash
    
(478,110
)
    
-
      
(478,110
)
 
                        
Cash - beginning of the period
    
501,242
      
-
      
501,242
  
Cash - end of the period
  
$
23,132
    
$
-
    
$
23,132
  
 
                        
Supplemental disclosure of noncash investing and financing activities:
                        
Extinguishment of deferred underwriting commissions allocated to public shares
  
$
-
    
$
2,616,250
    
$
2,616,250